Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
11.40
-0.50 (-4.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
4 Analysts Have This to Say About Iovance Biotherapeutics
May 24, 2022
Within the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings:
Via
Benzinga
Iovance Biotherapeutics Just Flashed A Bullish Sign Despite Melanoma Drug Delay
April 07, 2022
This biotech stock is mounting a two-day recovery and is well above its 50-day line.
Via
Investor's Business Daily
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Iovance Outlines Frontline Melanoma Strategy For Lifileucel / Pembrolizumab Combo Therapy
April 06, 2022
The
Via
Benzinga
All The Stocks That Moved Wednesday From CNBC's 'Fast Money: Halftime Report'
March 23, 2022
CNBC's "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often move the stocks mentioned....
Via
Benzinga
Iovance Receives FDA Allowance For IOV-4001 Study In Two Advanced Cancers
March 16, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study
March 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 15, 2022
Gainers
Via
Benzinga
Recap: Iovance Biotherapeutics Q4 Earnings
February 24, 2022
Iovance Biotherapeutics (NASDAQ:IOVA) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
Iovance's Lifileucel Combo Shows Encouraging Response Rates In Advanced Cancers
November 15, 2021
Iovance Biotherapeutics Inc (NASDAQ: IOVA) has announced data for lifileucel in combination with Merck Co Inc's (NYSE: MRK) Keytruda (pembrolizumab)...
Via
Benzinga
70 Biggest Movers From Friday
November 15, 2021
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4...
Via
Benzinga
Iovance Shares Tumble After Cell Therapy Data From Lung Cancer Trial
November 12, 2021
Iovance Biotherapeutics Inc (NASDAQ: IOVA) has announced additional data for LN-145 in patients with metastatic non-small cell lung cancer (mNSCLC) enrolled in...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 12, 2021
Gainers SOC Telemed (NASDAQ:TLMD) stock increased by 30.04% to $2.77 during Friday's regular session. The current volume of 1.9 million shares is 238.17% of SOC...
Via
Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 12, 2021
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares climbed 41% to $9.28 after the company reported better-than-expected Q3results and issued Q4 sales guidance above...
Via
Benzinga
Iovance Biotherapeutics, inc (IOVA) Q3 2021 Earnings Call Transcript
November 05, 2021
IOVA earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Friday's After-Market Session
September 17, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Why Iovance Is Up Nearly 11% Today
September 15, 2021
Investors are starting to connect some drug development dots... with a little help.
Via
The Motley Fool
Cathie Wood's Ark ETFs Underperformed The Broader Market In Q2, With Workhorse, Virgin Galactic, Coinbase, Teladoc Taking Big Toll
July 15, 2021
ARK Invest, the New York-based investment management firm led by the popular money manager Cathie Wood, saw its five actively managed exchange-traded funds and two self-indexed...
Via
Benzinga
Why Iovance Biotherapeutics Soared 40% In June
July 08, 2021
The biopharma outfit has put some red flags in the rearview mirror, and sees a plausible approval on the horizon.
Via
The Motley Fool
June’s Best and Worst Performing Russell 1,000 Stocks
June 29, 2021
The month of June, the second quarter and the first half of 2021 are almost in the bag.
Via
Talk Markets
Iovance Biotherapeutics' TIL Therapy Achieves ORR Of 21.4% In Pre-Treated Lung Cancer Patients
June 29, 2021
Iovance Biotherapeutics Inc (NASDAQ: IOVA) has announced clinical data for its tumor-infiltrating lymphocyte (TIL) therapy LN-145 in patients with metastatic non-...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 29, 2021
Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) shares moved upwards by 42.0% to $17.85 during Tuesday's pre-market session. The company's market cap stands at $2....
Via
Benzinga
Should You Buy This Cathie Wood Biotech Stock?
June 17, 2021
This biotech's fumble has caught the attention of a fund manager known for making innovative investments.
Via
The Motley Fool
Best and Worst Russell 1000 Stocks So Far in June
June 16, 2021
Right at the midpoint of June, Biogen has been the top-performing Russell 1,000 stock month to date.
Via
Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
June 10, 2021
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares...
Via
Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
June 07, 2021
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.